The company's expansion in the biological assay space aided by the data platform SAN FRANCISCO and KYIV, Ukraine, June 10, 2021 /PRNewswire/ -- Enamine, a leading provider of R&D Services as well as ...
Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate 2,000 new compounds generated ...
AI drug discovery company Syntekabio has partnered with Ukraine-based global compound supplier Enamine for supply, synthesis of compounds and synthetic drug development. Under the Memorandum of ...
KYIV, Ukraine & SANKT AUGUSTIN, Germany--(BUSINESS WIRE)--The two leading experts in the exploration of ultra-large make-on-demand chemical spaces join forces to spark a new era of drug discovery.
SAN FRANCISCO & KIEV, Ukraine--(BUSINESS WIRE)--Atomwise, Inc. today announced the launch of a 10 billion compound AI-powered virtual drug screening initiative, the 10-to-the-10 program, in ...
Nuclide Therapeutics Leverages Enamine’s Deep Expertise in Rapid and Scalable Synthesis of Small Molecules KYIV, UKRAINE, April 2, 2026 /EINPresswire.com ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results